Sarvodaya Hospital, Sector 8, Faridabad

The Importance of Liver Monitoring and Management Strategies for Viral Hepatitis B and C

Viral Hepatitis B and C are significant public health challenges in India, often termed "silent killers" due to their prolonged asymptomatic latency period. The viruses can cause progressive liver damage, leading to advanced conditions such as liver cirrhosis and liver cancer before any symptoms manifest, contributing substantially to liver-related mortality in the country.

Disease Characteristics and Transmission

Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are pathogens that infect the liver, causing inflammation and, over time, irreversible damage. The primary modes of transmission include:

• Contact with infected blood

• Unprotected sexual contact

  
  

• Unsafe injection practices

• Perinatal (mother-to-child) transmission

  
  

The asymptomatic nature of the initial stages is a critical concern, as infected individuals can unknowingly transmit the virus while experiencing gradual, internal liver deterioration. According to the World Health Organisation (WHO), an estimated 40 million people in India are living with chronic Hepatitis B and 6-12 million with chronic Hepatitis C, a majority of whom are undiagnosed.

Rationale for Regular Liver Monitoring

Consistent monitoring is crucial for the early detection of infection and the management of disease progression, thereby preventing severe complications. Key monitoring procedures include:

• Regular liver function tests

• Viral load quantification

• Ultrasound imaging

This is particularly vital for high-risk populations, such as healthcare professionals, recipients of multiple blood transfusions, injection drug users, and family members of infected individuals. Regular monitoring enables healthcare providers to initiate timely antiviral treatments. Current therapies for Hepatitis C can achieve a cure rate of over within 12 weeks. For Hepatitis B, while a cure is not yet available, antiviral medications can effectively suppress the virus, preventing the progression to liver failure or cancer.

National Strategies for Viral Hepatitis Elimination

In line with WHO's global goals, India has committed to eliminating viral hepatitis as a public health threat by 2030. Key strategies to achieve this include:

• Universal Screening: Implementing comprehensive screening programs, with a focus on high-risk groups such as pregnant women, dialysis patients, and healthcare workers.

• Vaccination: Improving coverage of the effective Hepatitis B vaccine, which is part of India's Universal Immunisation Programme, and promoting adult immunization.

• Safe Medical Practices: Enforce stringent protocols for safe injections, blood transfusions, and general infection control in all healthcare facilities.

• Awareness Campaigns: Increasing public knowledge to reduce stigma and encourage testing and preventive measures.

• Accessible Care: Providing free testing and treatment under the National Viral Hepatitis Control Programme (NVHCP).

  
  

In conclusion, while Hepatitis B and C are preventable and treatable diseases, their impact in India is magnified by a high rate of undiagnosed cases. Enhancing public awareness, implementing routine liver monitoring, and strengthening public health systems are essential to control these infections and move towards a hepatitis-free future.